Pharmacology: Parenteral nutrient solution with an amino acid (AA) pattern adjusted to the altered AA metabolism of patients with hepatic insufficiency. The high concentration of branched-chain AA (Isoleucine, Leucine, and Valine) and low content of Methionine, Phenylalanine and Tryptophan influence CNS function.
In some cases, this reduce the risk of neurological deterioration which previously present in patients with serious liver disease receiving parenteral nutrition in the form of standard amino acid solution. This solution could increase mental alertness in cases where sensory disorders due to hepatic insufficiency are present.
Another factors which have contribution is the use of reliable substances which back up the detoxication functions of the diseased liver e.g. Ornithine Aspartate, Arginine, Malate (Malic Acid) and electrolyte pattern adjustment into specific needs of liver disease patients, e.g. reduced Na+, average K+ and increased Mg++ content.